fanta.bio Sample: CNhs10876
14309 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 977 / 9693 (10.1%) | 289 / 96930 (0.3%) | −324.0 | −324.0 | 33.81 |
| HIF1A SRX11007095 | HK-2 Kidney | 1841 / 9693 (19.0%) | 622 / 96930 (0.6%) | −324.0 | −324.0 | 29.60 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1414 / 9693 (14.6%) | 492 / 96930 (0.5%) | −324.0 | −324.0 | 28.74 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1306 / 9693 (13.5%) | 523 / 96930 (0.5%) | −324.0 | −324.0 | 24.97 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1804 / 9693 (18.6%) | 797 / 96930 (0.8%) | −324.0 | −324.0 | 22.63 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1749 / 9693 (18.0%) | 778 / 96930 (0.8%) | −324.0 | −324.0 | 22.48 |
| SCML2 SRX644728 | 293 Kidney | 1032 / 9693 (10.6%) | 501 / 96930 (0.5%) | −324.0 | −324.0 | 20.60 |
| FOXP1 SRX736067 | LNCAP Prostate | 1263 / 9693 (13.0%) | 818 / 96930 (0.8%) | −324.0 | −324.0 | 15.44 |
| MYH11 SRX265221 | ME-1 Blood | 623 / 9693 (6.4%) | 455 / 96930 (0.5%) | −324.0 | −324.0 | 13.69 |
| BRD4 SRX9419935 | BT-474 Breast | 2536 / 9693 (26.2%) | 1908 / 96930 (2.0%) | −324.0 | −324.0 | 13.29 |
| BRD4 SRX9419937 | BT-474 Breast | 2504 / 9693 (25.8%) | 1913 / 96930 (2.0%) | −324.0 | −324.0 | 13.09 |
| MED1 SRX9419944 | BT-474 Breast | 2446 / 9693 (25.2%) | 1878 / 96930 (1.9%) | −324.0 | −324.0 | 13.02 |
| BRD4 SRX9419936 | BT-474 Breast | 2560 / 9693 (26.4%) | 1999 / 96930 (2.1%) | −324.0 | −324.0 | 12.81 |
| MED1 SRX9419945 | BT-474 Breast | 2503 / 9693 (25.8%) | 1955 / 96930 (2.0%) | −324.0 | −324.0 | 12.80 |
| MED1 SRX9419946 | BT-474 Breast | 2550 / 9693 (26.3%) | 2021 / 96930 (2.1%) | −324.0 | −324.0 | 12.62 |
| BRD4 SRX9419938 | BT-474 Breast | 2510 / 9693 (25.9%) | 2024 / 96930 (2.1%) | −324.0 | −324.0 | 12.40 |
| MED1 SRX9419947 | BT-474 Breast | 2454 / 9693 (25.3%) | 1998 / 96930 (2.1%) | −324.0 | −324.0 | 12.28 |
| EZH2 SRX2146136 | LNCAP Prostate | 5276 / 9693 (54.4%) | 5125 / 96930 (5.3%) | −324.0 | −324.0 | 10.29 |
| BRD4 SRX736201 | 90-8TL Neural | 4223 / 9693 (43.6%) | 4204 / 96930 (4.3%) | −324.0 | −324.0 | 10.05 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1244 / 9693 (12.8%) | 1620 / 96930 (1.7%) | −324.0 | −324.0 | 7.68 |
| TP53 SRX19538279 | Osteoblasts Bone | 426 / 9693 (4.4%) | 166 / 96930 (0.2%) | −302.8 | −299.6 | 25.66 |
| HIF1A SRX20663235 | HK-2 Kidney | 388 / 9693 (4.0%) | 183 / 96930 (0.2%) | −260.3 | −257.2 | 21.20 |
| TP53 SRX19538268 | U2OS Bone | 347 / 9693 (3.6%) | 117 / 96930 (0.1%) | −256.1 | −252.9 | 29.66 |
| TP53 SRX19538274 | U2OS Bone | 346 / 9693 (3.6%) | 126 / 96930 (0.1%) | −250.3 | −247.1 | 27.46 |
| TP53 SRX19538276 | U2OS Bone | 339 / 9693 (3.5%) | 122 / 96930 (0.1%) | −245.9 | −242.8 | 27.79 |
| BRD4 SRX736204 | 90-8TL Neural | 801 / 9693 (8.3%) | 1627 / 96930 (1.7%) | −243.2 | −240.1 | 4.92 |
| 5-mC SRX882970 | LNCAP Prostate | 2023 / 9693 (20.9%) | 8797 / 96930 (9.1%) | −239.3 | −236.2 | 2.30 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 338 / 9693 (3.5%) | 139 / 96930 (0.1%) | −236.3 | −233.2 | 24.32 |
| TP53 SRX19538280 | Osteoblasts Bone | 334 / 9693 (3.4%) | 133 / 96930 (0.1%) | −235.7 | −232.6 | 25.11 |
| TP53 SRX19538273 | U2OS Bone | 314 / 9693 (3.2%) | 100 / 96930 (0.1%) | −235.0 | −231.9 | 31.40 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 911 / 9693 (9.4%) | 2204 / 96930 (2.3%) | −234.3 | −231.2 | 4.13 |
| IRF3 SRX11453858 | Hep G2 Liver | 277 / 9693 (2.9%) | 49 / 96930 (0.1%) | −233.3 | −230.3 | 56.53 |
| 5-mC SRX882968 | LNCAP Prostate | 1997 / 9693 (20.6%) | 8763 / 96930 (9.0%) | −231.6 | −228.6 | 2.28 |
| AGO2 SRX4708039 | Hep G2 Liver | 1299 / 9693 (13.4%) | 4320 / 96930 (4.5%) | −230.4 | −227.4 | 3.01 |
| TP53 SRX19538281 | Osteoblasts Bone | 352 / 9693 (3.6%) | 179 / 96930 (0.2%) | −230.3 | −227.3 | 19.66 |
| TP53 SRX19538267 | U2OS Bone | 310 / 9693 (3.2%) | 105 / 96930 (0.1%) | −228.4 | −225.4 | 29.52 |
| TP53 SRX19538275 | U2OS Bone | 316 / 9693 (3.3%) | 116 / 96930 (0.1%) | −228.0 | −225.0 | 27.24 |
| KAT6A SRX20971022 | Fibroblasts Others | 265 / 9693 (2.7%) | 46 / 96930 (0.0%) | −223.9 | −220.9 | 57.61 |
| TP53 SRX19538269 | U2OS Bone | 385 / 9693 (4.0%) | 270 / 96930 (0.3%) | −223.5 | −220.5 | 14.26 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1056 / 9693 (10.9%) | 3056 / 96930 (3.2%) | −222.7 | −219.8 | 3.46 |
| TP53 SRX19538270 | U2OS Bone | 356 / 9693 (3.7%) | 253 / 96930 (0.3%) | −205.4 | −202.5 | 14.07 |
| 5-mC SRX882965 | LNCAP Prostate | 1636 / 9693 (16.9%) | 6807 / 96930 (7.0%) | −205.2 | −202.3 | 2.40 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 485 / 9693 (5.0%) | 640 / 96930 (0.7%) | −202.8 | −199.9 | 7.58 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 451 / 9693 (4.7%) | 561 / 96930 (0.6%) | −195.6 | −192.7 | 8.04 |
| RUNX1 SRX2513054 | 293 Kidney | 2113 / 9693 (21.8%) | 10341 / 96930 (10.7%) | −195.0 | −192.2 | 2.04 |
| IRF3 SRX11453861 | Hep G2 Liver | 240 / 9693 (2.5%) | 54 / 96930 (0.1%) | −193.6 | −190.8 | 44.44 |
| PBX4 SRX2731658 | PC-3 Prostate | 551 / 9693 (5.7%) | 15086 / 96930 (15.6%) | −185.2 | −182.4 | 0.37 |
| TP53 SRX19538271 | U2OS Bone | 484 / 9693 (5.0%) | 734 / 96930 (0.8%) | −184.1 | −181.2 | 6.59 |
| AR SRX10820653 | LNCAP Prostate | 267 / 9693 (2.8%) | 132 / 96930 (0.1%) | −176.2 | −173.4 | 20.23 |
| TP53 SRX19538282 | Osteoblasts Bone | 293 / 9693 (3.0%) | 196 / 96930 (0.2%) | −173.2 | −170.4 | 14.95 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 607 / 9693 (6.3%) | 1316 / 96930 (1.4%) | −172.2 | −169.4 | 4.61 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1371 / 9693 (14.1%) | 5671 / 96930 (5.9%) | −170.9 | −168.1 | 2.42 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 370 / 9693 (3.8%) | 414 / 96930 (0.4%) | −170.7 | −167.9 | 8.94 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 417 / 9693 (4.3%) | 570 / 96930 (0.6%) | −170.1 | −167.3 | 7.32 |
| Epitope tags SRX10549776 | K-562 Blood | 926 / 9693 (9.6%) | 3101 / 96930 (3.2%) | −159.5 | −156.7 | 2.99 |
| CIC SRX13262055 | Astrocytes Neural | 1896 / 9693 (19.6%) | 9728 / 96930 (10.0%) | −153.3 | −150.6 | 1.95 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 458 / 9693 (4.7%) | 828 / 96930 (0.9%) | −152.0 | −149.3 | 5.53 |
| AR SRX10820651 | LNCAP Prostate | 274 / 9693 (2.8%) | 214 / 96930 (0.2%) | −151.6 | −148.9 | 12.80 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 778 / 9693 (8.0%) | 2388 / 96930 (2.5%) | −150.2 | −147.4 | 3.26 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 207 / 9693 (2.1%) | 78 / 96930 (0.1%) | −148.2 | −145.5 | 26.54 |
| FOXA1 SRX4815198 | MCF-7 Breast | 559 / 9693 (5.8%) | 13846 / 96930 (14.3%) | −145.3 | −142.6 | 0.40 |
| YAP1 SRX757325 | H2052 Lung | 415 / 9693 (4.3%) | 11566 / 96930 (11.9%) | −141.3 | −138.6 | 0.36 |
| TP53 SRX19538272 | U2OS Bone | 401 / 9693 (4.1%) | 673 / 96930 (0.7%) | −141.1 | −138.4 | 5.96 |
| AGO2 SRX6783957 | Hep G2 Liver | 792 / 9693 (8.2%) | 2578 / 96930 (2.7%) | −141.1 | −138.4 | 3.07 |
| AGO2 SRX6783958 | Hep G2 Liver | 787 / 9693 (8.1%) | 2562 / 96930 (2.6%) | −140.2 | −137.4 | 3.07 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 337 / 9693 (3.5%) | 464 / 96930 (0.5%) | −136.6 | −133.9 | 7.26 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 442 / 9693 (4.6%) | 879 / 96930 (0.9%) | −135.2 | −132.5 | 5.03 |
| FOXA1 SRX4815197 | MCF-7 Breast | 411 / 9693 (4.2%) | 11287 / 96930 (11.6%) | −134.9 | −132.2 | 0.36 |
| FOXA1 SRX176862 | MCF-7 Breast | 203 / 9693 (2.1%) | 7895 / 96930 (8.1%) | −134.7 | −132.0 | 0.26 |
| YAP1 SRX757326 | H2052 Lung | 350 / 9693 (3.6%) | 10334 / 96930 (10.7%) | −134.7 | −132.0 | 0.34 |
| STAT5B SRX831881 | CD8+ T cells Blood | 199 / 9693 (2.1%) | 94 / 96930 (0.1%) | −133.3 | −130.6 | 21.17 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 373 / 9693 (3.8%) | 10635 / 96930 (11.0%) | −132.9 | −130.3 | 0.35 |
| FOXA1 SRX176863 | MCF-7 Breast | 194 / 9693 (2.0%) | 7510 / 96930 (7.7%) | −127.4 | −124.7 | 0.26 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 860 / 9693 (8.9%) | 3197 / 96930 (3.3%) | −125.5 | −122.9 | 2.69 |
| ESR1 SRX7624157 | MCF-7 Breast | 462 / 9693 (4.8%) | 11702 / 96930 (12.1%) | −124.9 | −122.3 | 0.39 |
| FOXA1 SRX3931044 | MCF-7 Breast | 378 / 9693 (3.9%) | 10424 / 96930 (10.8%) | −124.6 | −121.9 | 0.36 |
| TRP47 SRX4548329 | THP-1 Blood | 1581 / 9693 (16.3%) | 8148 / 96930 (8.4%) | −123.5 | −120.9 | 1.94 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 170 / 9693 (1.8%) | 61 / 96930 (0.1%) | −123.4 | −120.8 | 27.87 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1066 / 9693 (11.0%) | 4549 / 96930 (4.7%) | −123.0 | −120.4 | 2.34 |
| FOS SRX150477 | MCF 10A Breast | 435 / 9693 (4.5%) | 11184 / 96930 (11.5%) | −121.7 | −119.1 | 0.39 |
| FOS SRX150478 | MCF 10A Breast | 452 / 9693 (4.7%) | 11413 / 96930 (11.8%) | −121.0 | −118.4 | 0.40 |
| SREBF2 SRX5359048 | HCC70 Breast | 1035 / 9693 (10.7%) | 4444 / 96930 (4.6%) | −117.7 | −115.1 | 2.33 |
| BMI1 SRX644729 | 293 Kidney | 177 / 9693 (1.8%) | 86 / 96930 (0.1%) | −117.5 | −114.9 | 20.58 |
| ESR1 SRX371478 | MCF-7 Breast | 230 / 9693 (2.4%) | 7821 / 96930 (8.1%) | −117.3 | −114.7 | 0.29 |
| ESR1 SRX371469 | MCF-7 Breast | 179 / 9693 (1.8%) | 6919 / 96930 (7.1%) | −116.7 | −114.1 | 0.26 |
| GATA3 SRX190239 | MCF-7 Breast | 260 / 9693 (2.7%) | 8293 / 96930 (8.6%) | −116.6 | −114.0 | 0.31 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 126 / 9693 (1.3%) | 5891 / 96930 (6.1%) | −114.9 | −112.3 | 0.21 |
| FOXA1 SRX1161177 | MCF-7 Breast | 178 / 9693 (1.8%) | 6836 / 96930 (7.1%) | −114.6 | −112.0 | 0.26 |
| ESR1 SRX7624156 | MCF-7 Breast | 295 / 9693 (3.0%) | 8775 / 96930 (9.1%) | −114.1 | −111.6 | 0.34 |
| ESR1 SRX20282961 | MCF-7 Breast | 228 / 9693 (2.4%) | 7667 / 96930 (7.9%) | −113.6 | −111.0 | 0.30 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 330 / 9693 (3.4%) | 570 / 96930 (0.6%) | −113.4 | −110.8 | 5.79 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 150 / 9693 (1.5%) | 47 / 96930 (0.0%) | −112.7 | −110.2 | 31.91 |
| TLE3 SRX4815191 | MCF-7 Breast | 171 / 9693 (1.8%) | 6591 / 96930 (6.8%) | −110.6 | −108.1 | 0.26 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 155 / 9693 (1.6%) | 60 / 96930 (0.1%) | −110.3 | −107.7 | 25.83 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 412 / 9693 (4.3%) | 10430 / 96930 (10.8%) | −110.2 | −107.7 | 0.40 |
| ESR1 SRX371476 | MCF-7 Breast | 127 / 9693 (1.3%) | 5738 / 96930 (5.9%) | −109.1 | −106.5 | 0.22 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 348 / 9693 (3.6%) | 672 / 96930 (0.7%) | −109.0 | −106.5 | 5.18 |
| NFYB SRX16608147 | HeLa Uterus | 186 / 9693 (1.9%) | 128 / 96930 (0.1%) | −108.7 | −106.2 | 14.53 |
| RAC1 SRX10365541 | MCF-7 Breast | 81 / 9693 (0.8%) | 4800 / 96930 (5.0%) | −108.3 | −105.8 | 0.17 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 179 / 9693 (1.8%) | 6655 / 96930 (6.9%) | −108.1 | −105.6 | 0.27 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 226 / 9693 (2.3%) | 7441 / 96930 (7.7%) | −107.7 | −105.2 | 0.30 |
| GATA3 SRX5057632 | MCF-7 Breast | 109 / 9693 (1.1%) | 5350 / 96930 (5.5%) | −107.7 | −105.2 | 0.20 |
| CDK9 SRX7366783 | MCF-7 Breast | 174 / 9693 (1.8%) | 104 / 96930 (0.1%) | −107.5 | −105.0 | 16.73 |
| RUNX1 SRX2014504 | Jurkat Blood | 1439 / 9693 (14.8%) | 7516 / 96930 (7.8%) | −107.5 | −105.0 | 1.91 |
| ESR1 SRX371470 | ZR-75-1 Breast | 163 / 9693 (1.7%) | 6339 / 96930 (6.5%) | −107.2 | −104.7 | 0.26 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 221 / 9693 (2.3%) | 7339 / 96930 (7.6%) | −107.1 | −104.6 | 0.30 |
| FOXA1 SRX1161173 | MCF-7 Breast | 141 / 9693 (1.5%) | 5928 / 96930 (6.1%) | −106.7 | −104.3 | 0.24 |
| ESR1 SRX371479 | MCF-7 Breast | 172 / 9693 (1.8%) | 6474 / 96930 (6.7%) | −106.4 | −103.9 | 0.27 |
| BMI1 SRX7196721 | SF8628 Neural | 1017 / 9693 (10.5%) | 4553 / 96930 (4.7%) | −106.2 | −103.7 | 2.23 |
| ESR1 SRX194572 | MCF-7 Breast | 106 / 9693 (1.1%) | 5241 / 96930 (5.4%) | −106.0 | −103.5 | 0.20 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 969 / 9693 (10.0%) | 4237 / 96930 (4.4%) | −105.9 | −103.4 | 2.29 |
| FOXA1 SRX371482 | MCF-7 Breast | 280 / 9693 (2.9%) | 8254 / 96930 (8.5%) | −105.8 | −103.3 | 0.34 |
| MethylCap SRX014767 | NB-4 Blood | 1040 / 9693 (10.7%) | 4719 / 96930 (4.9%) | −105.7 | −103.3 | 2.20 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 497 / 9693 (5.1%) | 1406 / 96930 (1.5%) | −105.3 | −102.9 | 3.53 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 532 / 9693 (5.5%) | 1595 / 96930 (1.6%) | −104.9 | −102.5 | 3.34 |
| FOXA1 SRX1161176 | MCF-7 Breast | 178 / 9693 (1.8%) | 6526 / 96930 (6.7%) | −104.6 | −102.2 | 0.27 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1075 / 9693 (11.1%) | 5003 / 96930 (5.2%) | −103.6 | −101.2 | 2.15 |
| GATA3 SRX176864 | MCF-7 Breast | 132 / 9693 (1.4%) | 5663 / 96930 (5.8%) | −103.4 | −101.0 | 0.23 |
| ESR1 SRX371471 | ZR-75-1 Breast | 208 / 9693 (2.1%) | 7001 / 96930 (7.2%) | −103.4 | −101.0 | 0.30 |
| ESR1 SRX20282960 | MCF-7 Breast | 220 / 9693 (2.3%) | 7203 / 96930 (7.4%) | −103.4 | −101.0 | 0.31 |
| MITF SRX1555436 | 501A Epidermis | 1150 / 9693 (11.9%) | 5538 / 96930 (5.7%) | −103.1 | −100.7 | 2.08 |
| FOXA1 SRX371481 | MCF-7 Breast | 206 / 9693 (2.1%) | 6951 / 96930 (7.2%) | −102.9 | −100.5 | 0.30 |
| ESR1 SRX1531791 | MCF-7 Breast | 183 / 9693 (1.9%) | 6551 / 96930 (6.8%) | −102.7 | −100.2 | 0.28 |
| ESR1 SRX20282939 | MCF-7 Breast | 224 / 9693 (2.3%) | 7223 / 96930 (7.5%) | −102.1 | −99.6 | 0.31 |
| FOXA1 SRX371483 | MCF-7 Breast | 226 / 9693 (2.3%) | 7254 / 96930 (7.5%) | −102.0 | −99.6 | 0.31 |
| RAC1 SRX10365543 | MCF-7 Breast | 89 / 9693 (0.9%) | 4784 / 96930 (4.9%) | −102.0 | −99.6 | 0.19 |
| ESR1 SRX4367193 | MCF-7 Breast | 656 / 9693 (6.8%) | 13537 / 96930 (14.0%) | −101.8 | −99.4 | 0.48 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1131 / 9693 (11.7%) | 5441 / 96930 (5.6%) | −101.4 | −99.0 | 2.08 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 343 / 9693 (3.5%) | 9058 / 96930 (9.3%) | −100.9 | −98.5 | 0.38 |
| ESR1 SRX194569 | MCF-7 Breast | 204 / 9693 (2.1%) | 6845 / 96930 (7.1%) | −100.7 | −98.3 | 0.30 |
| FOXA1 SRX371480 | MCF-7 Breast | 128 / 9693 (1.3%) | 5490 / 96930 (5.7%) | −100.3 | −97.9 | 0.23 |
| ESR1 SRX20282972 | MCF-7 Breast | 222 / 9693 (2.3%) | 7130 / 96930 (7.4%) | −100.2 | −97.8 | 0.31 |
| CDK9 SRX7366781 | MCF-7 Breast | 162 / 9693 (1.7%) | 97 / 96930 (0.1%) | −100.1 | −97.7 | 16.70 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 179 / 9693 (1.8%) | 6392 / 96930 (6.6%) | −99.9 | −97.5 | 0.28 |
| KAT7 SRX101303 | RKO Digestive tract | 767 / 9693 (7.9%) | 3042 / 96930 (3.1%) | −99.9 | −97.5 | 2.52 |
| FOS SRX4192880 | MCF 10A Breast | 351 / 9693 (3.6%) | 9124 / 96930 (9.4%) | −99.4 | −97.0 | 0.38 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 175 / 9693 (1.8%) | 6303 / 96930 (6.5%) | −99.2 | −96.8 | 0.28 |
| BRD1 SRX286203 | RKO Digestive tract | 662 / 9693 (6.8%) | 2416 / 96930 (2.5%) | −98.8 | −96.4 | 2.74 |
| FOXA1 SRX1161175 | MCF-7 Breast | 144 / 9693 (1.5%) | 5735 / 96930 (5.9%) | −98.5 | −96.2 | 0.25 |
| ESR1 SRX371468 | MCF-7 Breast | 119 / 9693 (1.2%) | 5273 / 96930 (5.4%) | −98.5 | −96.2 | 0.23 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 179 / 9693 (1.8%) | 6342 / 96930 (6.5%) | −98.3 | −95.9 | 0.28 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 258 / 9693 (2.7%) | 7642 / 96930 (7.9%) | −98.1 | −95.8 | 0.34 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 453 / 9693 (4.7%) | 1261 / 96930 (1.3%) | −97.8 | −95.5 | 3.59 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 300 / 9693 (3.1%) | 8288 / 96930 (8.6%) | −97.8 | −95.4 | 0.36 |
| FOXA1 SRX1787653 | MCF-7 Breast | 160 / 9693 (1.7%) | 5976 / 96930 (6.2%) | −97.2 | −94.9 | 0.27 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 135 / 9693 (1.4%) | 5529 / 96930 (5.7%) | −97.2 | −94.8 | 0.24 |
| MethylCap SRX014766 | NB-4 Blood | 926 / 9693 (9.6%) | 4144 / 96930 (4.3%) | −96.3 | −93.9 | 2.23 |
| ESR1 SRX371477 | MCF-7 Breast | 87 / 9693 (0.9%) | 4574 / 96930 (4.7%) | −95.9 | −93.5 | 0.19 |
| ESR1 SRX176860 | MCF-7 Breast | 345 / 9693 (3.6%) | 8893 / 96930 (9.2%) | −95.5 | −93.2 | 0.39 |
| Epitope tags SRX392690 | T3M-1 Cl-10 Others | 127 / 9693 (1.3%) | 40 / 96930 (0.0%) | −95.4 | −93.1 | 31.75 |
| TEAD1 SRX3401272 | MCF-7 Breast | 145 / 9693 (1.5%) | 5646 / 96930 (5.8%) | −95.2 | −92.9 | 0.26 |
| ESR1 SRX176861 | MCF-7 Breast | 346 / 9693 (3.6%) | 8891 / 96930 (9.2%) | −95.0 | −92.6 | 0.39 |
| MECOM SRX23677896 | HNT-34 Blood | 1227 / 9693 (12.7%) | 6289 / 96930 (6.5%) | −95.0 | −92.6 | 1.95 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 298 / 9693 (3.1%) | 8160 / 96930 (8.4%) | −94.9 | −92.6 | 0.37 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 271 / 9693 (2.8%) | 7730 / 96930 (8.0%) | −94.7 | −92.4 | 0.35 |
| GATA3 SRX190194 | SK-N-SH Neural | 491 / 9693 (5.1%) | 10976 / 96930 (11.3%) | −94.6 | −92.3 | 0.45 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 431 / 9693 (4.4%) | 1185 / 96930 (1.2%) | −94.4 | −92.1 | 3.64 |
| LEO1 SRX1873456 | SEM Blood | 832 / 9693 (8.6%) | 3560 / 96930 (3.7%) | −94.3 | −92.0 | 2.34 |
| ESR1 SRX371467 | MCF-7 Breast | 220 / 9693 (2.3%) | 6846 / 96930 (7.1%) | −92.7 | −90.4 | 0.32 |
| ESR1 SRX10365536 | MCF-7 Breast | 100 / 9693 (1.0%) | 4734 / 96930 (4.9%) | −92.6 | −90.3 | 0.21 |
| VGLL1 SRX24602130 | BT-20 Breast | 213 / 9693 (2.2%) | 6722 / 96930 (6.9%) | −92.4 | −90.1 | 0.32 |
| FOXA1 SRX1787655 | MCF-7 Breast | 92 / 9693 (0.9%) | 4567 / 96930 (4.7%) | −92.4 | −90.0 | 0.20 |
| BRPF3 SRX796085 | RKO Digestive tract | 597 / 9693 (6.2%) | 2127 / 96930 (2.2%) | −92.3 | −90.0 | 2.81 |
| FOXA1 SRX3931043 | MCF-7 Breast | 208 / 9693 (2.1%) | 6628 / 96930 (6.8%) | −92.0 | −89.7 | 0.31 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 343 / 9693 (3.5%) | 8731 / 96930 (9.0%) | −91.9 | −89.6 | 0.39 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1045 / 9693 (10.8%) | 5062 / 96930 (5.2%) | −91.8 | −89.5 | 2.06 |
| ESR1 SRX10365532 | MCF-7 Breast | 103 / 9693 (1.1%) | 4753 / 96930 (4.9%) | −91.4 | −89.1 | 0.22 |
| FOXA1 SRX100454 | T-47D Breast | 274 / 9693 (2.8%) | 7659 / 96930 (7.9%) | −91.3 | −89.0 | 0.36 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 157 / 9693 (1.6%) | 5736 / 96930 (5.9%) | −91.2 | −88.9 | 0.27 |
| FOXA1 SRX100506 | Hep G2 Liver | 280 / 9693 (2.9%) | 7747 / 96930 (8.0%) | −91.2 | −88.9 | 0.36 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1080 / 9693 (11.1%) | 5328 / 96930 (5.5%) | −91.1 | −88.8 | 2.03 |
| Epitope tags SRX2867680 | 293 Kidney | 1182 / 9693 (12.2%) | 6070 / 96930 (6.3%) | −90.8 | −88.5 | 1.95 |
| BRPF3 SRX796084 | RKO Digestive tract | 833 / 9693 (8.6%) | 3637 / 96930 (3.8%) | −90.6 | −88.3 | 2.29 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 165 / 9693 (1.7%) | 5853 / 96930 (6.0%) | −90.6 | −88.3 | 0.28 |
| FOXA1 SRX1161174 | MCF-7 Breast | 213 / 9693 (2.2%) | 6657 / 96930 (6.9%) | −90.6 | −88.3 | 0.32 |
| FOXA1 SRX028634 | MCF-7 Breast | 97 / 9693 (1.0%) | 4595 / 96930 (4.7%) | −90.0 | −87.7 | 0.21 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 89 / 9693 (0.9%) | 4437 / 96930 (4.6%) | −89.9 | −87.6 | 0.20 |
| FOXA1 SRX11222437 | MCF-7 Breast | 146 / 9693 (1.5%) | 5495 / 96930 (5.7%) | −89.7 | −87.4 | 0.27 |
| ESR1 SRX4451213 | MCF-7 Breast | 210 / 9693 (2.2%) | 6581 / 96930 (6.8%) | −89.6 | −87.4 | 0.32 |
| AR SRX1067071 | LHSAR Prostate | 421 / 9693 (4.3%) | 9779 / 96930 (10.1%) | −89.4 | −87.2 | 0.43 |
| ESR1 SRX2943591 | MCF-7 Breast | 139 / 9693 (1.4%) | 5357 / 96930 (5.5%) | −89.3 | −87.1 | 0.26 |
| FOXA1 SRX1787651 | MCF-7 Breast | 115 / 9693 (1.2%) | 4915 / 96930 (5.1%) | −89.1 | −86.9 | 0.23 |
| YAP1 SRX5718140 | 293 Kidney | 373 / 9693 (3.8%) | 9072 / 96930 (9.4%) | −89.1 | −86.9 | 0.41 |
| ESR1 SRX371475 | BT-474 Breast | 97 / 9693 (1.0%) | 4572 / 96930 (4.7%) | −89.0 | −86.8 | 0.21 |
| SSRP1 SRX3436567 | HT-1080 Bone | 233 / 9693 (2.4%) | 350 / 96930 (0.4%) | −89.0 | −86.7 | 6.66 |
| FOXA1 SRX3923514 | MCF-7 Breast | 219 / 9693 (2.3%) | 6697 / 96930 (6.9%) | −88.8 | −86.6 | 0.33 |
| ARID1A SRX5089376 | MCF-7 Breast | 182 / 9693 (1.9%) | 6080 / 96930 (6.3%) | −88.6 | −86.3 | 0.30 |
| ESR1 SRX20282954 | MCF-7 Breast | 235 / 9693 (2.4%) | 6945 / 96930 (7.2%) | −88.5 | −86.3 | 0.34 |
| FOXA1 SRX028635 | MCF-7 Breast | 100 / 9693 (1.0%) | 4589 / 96930 (4.7%) | −87.7 | −85.4 | 0.22 |
| MECOM SRX23677897 | HNT-34 Blood | 1162 / 9693 (12.0%) | 6009 / 96930 (6.2%) | −87.5 | −85.2 | 1.93 |
| FOXA2 SRX100448 | Hep G2 Liver | 238 / 9693 (2.5%) | 6956 / 96930 (7.2%) | −87.4 | −85.2 | 0.34 |
| TLE3 SRX4815192 | MCF-7 Breast | 188 / 9693 (1.9%) | 6138 / 96930 (6.3%) | −87.3 | −85.0 | 0.31 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 892 / 9693 (9.2%) | 4110 / 96930 (4.2%) | −87.1 | −84.8 | 2.17 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1015 / 9693 (10.5%) | 4966 / 96930 (5.1%) | −86.9 | −84.7 | 2.04 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 726 / 9693 (7.5%) | 13822 / 96930 (14.3%) | −86.9 | −84.7 | 0.53 |
| FOXA1 SRX1787652 | MCF-7 Breast | 124 / 9693 (1.3%) | 5011 / 96930 (5.2%) | −86.8 | −84.6 | 0.25 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 287 / 9693 (3.0%) | 7691 / 96930 (7.9%) | −86.6 | −84.4 | 0.37 |
| AR SRX1067070 | LHSAR Prostate | 534 / 9693 (5.5%) | 11247 / 96930 (11.6%) | −86.6 | −84.3 | 0.47 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1014 / 9693 (10.5%) | 4967 / 96930 (5.1%) | −86.5 | −84.3 | 2.04 |
| BRPF3 SRX796086 | RKO Digestive tract | 791 / 9693 (8.2%) | 3446 / 96930 (3.6%) | −86.2 | −84.0 | 2.30 |
| AR SRX9469988 | LAPC-4 Prostate | 288 / 9693 (3.0%) | 7690 / 96930 (7.9%) | −86.2 | −84.0 | 0.37 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1076 / 9693 (11.1%) | 5421 / 96930 (5.6%) | −86.0 | −83.8 | 1.98 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 979 / 9693 (10.1%) | 4738 / 96930 (4.9%) | −85.9 | −83.7 | 2.07 |
| TET2 SRX2014505 | Jurkat Blood | 1489 / 9693 (15.4%) | 8526 / 96930 (8.8%) | −85.7 | −83.5 | 1.75 |
| FOXA1 SRX11222441 | MCF-7 Breast | 165 / 9693 (1.7%) | 5697 / 96930 (5.9%) | −85.7 | −83.5 | 0.29 |
| FOXA1 SRX3931055 | MCF-7 Breast | 179 / 9693 (1.8%) | 5932 / 96930 (6.1%) | −85.7 | −83.5 | 0.30 |
| DNMT3B SRX2862487 | hESC HUES8 Pluripotent stem cell | 180 / 9693 (1.9%) | 192 / 96930 (0.2%) | −85.4 | −83.2 | 9.38 |
| GATA3 SRX6712581 | MCF-7 Breast | 172 / 9693 (1.8%) | 5803 / 96930 (6.0%) | −85.3 | −83.1 | 0.30 |
| JUNB SRX8488088 | SUM 229PE Breast | 422 / 9693 (4.4%) | 9630 / 96930 (9.9%) | −85.3 | −83.1 | 0.44 |
| FOXA1 SRX11222442 | MCF-7 Breast | 143 / 9693 (1.5%) | 5298 / 96930 (5.5%) | −85.2 | −83.0 | 0.27 |
| ESR1 SRX4451212 | MCF-7 Breast | 201 / 9693 (2.1%) | 6273 / 96930 (6.5%) | −84.9 | −82.7 | 0.32 |
| FOXA1 SRX3931054 | MCF-7 Breast | 199 / 9693 (2.1%) | 6238 / 96930 (6.4%) | −84.8 | −82.6 | 0.32 |
| ESR1 SRX2943589 | MCF-7 Breast | 102 / 9693 (1.1%) | 4540 / 96930 (4.7%) | −84.8 | −82.6 | 0.22 |
| TET2 SRX1427029 | 293 Kidney | 733 / 9693 (7.6%) | 3096 / 96930 (3.2%) | −84.7 | −82.5 | 2.37 |
| GATA3 SRX5457550 | MCF-7 Breast | 244 / 9693 (2.5%) | 6954 / 96930 (7.2%) | −84.7 | −82.5 | 0.35 |
| ESR1 SRX20282940 | MCF-7 Breast | 241 / 9693 (2.5%) | 6898 / 96930 (7.1%) | −84.4 | −82.2 | 0.35 |
| ARID1A SRX5089379 | MCF-7 Breast | 217 / 9693 (2.2%) | 6511 / 96930 (6.7%) | −84.3 | −82.1 | 0.33 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 101 / 9693 (1.0%) | 4495 / 96930 (4.6%) | −84.0 | −81.8 | 0.22 |
| MECOM SRX23677885 | HNT-34 Blood | 983 / 9693 (10.1%) | 4813 / 96930 (5.0%) | −83.9 | −81.7 | 2.04 |
| FOXA1 SRX3923517 | MCF-7 Breast | 154 / 9693 (1.6%) | 5440 / 96930 (5.6%) | −83.7 | −81.5 | 0.28 |
| ESR1 SRX10365535 | MCF-7 Breast | 176 / 9693 (1.8%) | 5817 / 96930 (6.0%) | −83.6 | −81.5 | 0.30 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 283 / 9693 (2.9%) | 7521 / 96930 (7.8%) | −83.5 | −81.4 | 0.38 |
| FOXA1 SRX5203303 | MCF-7 Breast | 67 / 9693 (0.7%) | 3797 / 96930 (3.9%) | −83.1 | −80.9 | 0.18 |
| EP300 SRX176885 | MCF-7 Breast | 110 / 9693 (1.1%) | 4637 / 96930 (4.8%) | −83.1 | −80.9 | 0.24 |
| FOXA1 SRX11222438 | MCF-7 Breast | 112 / 9693 (1.2%) | 4666 / 96930 (4.8%) | −82.8 | −80.6 | 0.24 |
| ESR1 SRX20282973 | MCF-7 Breast | 267 / 9693 (2.8%) | 7247 / 96930 (7.5%) | −82.8 | −80.6 | 0.37 |
| ESR1 SRX20282946 | MCF-7 Breast | 129 / 9693 (1.3%) | 4964 / 96930 (5.1%) | −82.4 | −80.2 | 0.26 |
| FOXA1 SRX3923516 | MCF-7 Breast | 157 / 9693 (1.6%) | 5447 / 96930 (5.6%) | −82.3 | −80.1 | 0.29 |
| FOXA1 SRX5323843 | MCF-7 Breast | 111 / 9693 (1.1%) | 4632 / 96930 (4.8%) | −82.2 | −80.1 | 0.24 |
| FOXA2 SRX3230382 | Hep G2 Liver | 305 / 9693 (3.1%) | 7799 / 96930 (8.0%) | −82.1 | −80.0 | 0.39 |
| ESR1 SRX2881000 | MCF-7 Breast | 195 / 9693 (2.0%) | 6068 / 96930 (6.3%) | −81.8 | −79.7 | 0.32 |
| FOS SRX150476 | MCF 10A Breast | 394 / 9693 (4.1%) | 9095 / 96930 (9.4%) | −81.8 | −79.7 | 0.43 |
| FOXA1 SRX1161203 | T-47D Breast | 154 / 9693 (1.6%) | 5378 / 96930 (5.5%) | −81.7 | −79.5 | 0.29 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 191 / 9693 (2.0%) | 5999 / 96930 (6.2%) | −81.6 | −79.5 | 0.32 |
| VGLL1 SRX18013277 | FULVR Breast | 86 / 9693 (0.9%) | 4136 / 96930 (4.3%) | −81.6 | −79.4 | 0.21 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 245 / 9693 (2.5%) | 6854 / 96930 (7.1%) | −81.3 | −79.2 | 0.36 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 234 / 9693 (2.4%) | 6670 / 96930 (6.9%) | −81.1 | −78.9 | 0.35 |
| ESR1 SRX20282955 | MCF-7 Breast | 238 / 9693 (2.5%) | 6722 / 96930 (6.9%) | −80.8 | −78.7 | 0.35 |
| LARP7 SRX2198835 | HeLa Uterus | 1171 / 9693 (12.1%) | 6257 / 96930 (6.5%) | −80.8 | −78.6 | 1.87 |
| EP300 SRX2671820 | iPS cells Pluripotent stem cell | 41 / 9693 (0.4%) | 3156 / 96930 (3.3%) | −80.6 | −78.4 | 0.13 |
| FOS SRX150517 | MCF 10A Breast | 397 / 9693 (4.1%) | 9079 / 96930 (9.4%) | −80.5 | −78.3 | 0.44 |
| ESR1 SRX371474 | BT-474 Breast | 98 / 9693 (1.0%) | 4333 / 96930 (4.5%) | −80.4 | −78.3 | 0.23 |
| ESR1 SRX10365533 | MCF-7 Breast | 102 / 9693 (1.1%) | 4403 / 96930 (4.5%) | −80.2 | −78.1 | 0.23 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 195 / 9693 (2.0%) | 6013 / 96930 (6.2%) | −80.2 | −78.1 | 0.32 |
| ERG SRX063922 | K-562 Blood | 867 / 9693 (8.9%) | 4092 / 96930 (4.2%) | −80.1 | −78.0 | 2.12 |
| FOXA1 SRX1447317 | MCF-7 Breast | 147 / 9693 (1.5%) | 5201 / 96930 (5.4%) | −79.9 | −77.8 | 0.28 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 742 / 9693 (7.7%) | 13704 / 96930 (14.1%) | −79.8 | −77.7 | 0.54 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 156 / 9693 (1.6%) | 5347 / 96930 (5.5%) | −79.8 | −77.6 | 0.29 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 252 / 9693 (2.6%) | 6903 / 96930 (7.1%) | −79.6 | −77.5 | 0.37 |
| AR SRX1067066 | LHSAR Prostate | 481 / 9693 (5.0%) | 10218 / 96930 (10.5%) | −79.5 | −77.4 | 0.47 |
| MECOM SRX23677884 | HNT-34 Blood | 960 / 9693 (9.9%) | 4758 / 96930 (4.9%) | −79.4 | −77.3 | 2.02 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 220 / 9693 (2.3%) | 6388 / 96930 (6.6%) | −79.4 | −77.3 | 0.34 |
| CEBPB SRX150632 | HeLa Uterus | 511 / 9693 (5.3%) | 10626 / 96930 (11.0%) | −79.3 | −77.2 | 0.48 |
| ESR1 SRX792933 | LY2 Breast | 183 / 9693 (1.9%) | 5785 / 96930 (6.0%) | −79.3 | −77.2 | 0.32 |
| RORC SRX5359053 | HCC70 Breast | 701 / 9693 (7.2%) | 2997 / 96930 (3.1%) | −79.1 | −77.0 | 2.34 |
| NR2F2 SRX190293 | MCF-7 Breast | 240 / 9693 (2.5%) | 6690 / 96930 (6.9%) | −79.0 | −76.8 | 0.36 |
| ESR1 SRX10365534 | MCF-7 Breast | 61 / 9693 (0.6%) | 3551 / 96930 (3.7%) | −78.9 | −76.8 | 0.17 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 213 / 9693 (2.2%) | 6251 / 96930 (6.4%) | −78.6 | −76.5 | 0.34 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 240 / 9693 (2.5%) | 6671 / 96930 (6.9%) | −78.4 | −76.3 | 0.36 |
| EP300 SRX2671806 | iPS cells Pluripotent stem cell | 35 / 9693 (0.4%) | 2954 / 96930 (3.0%) | −78.3 | −76.2 | 0.12 |
| FOXA1 SRX3923518 | MCF-7 Breast | 158 / 9693 (1.6%) | 5334 / 96930 (5.5%) | −78.3 | −76.2 | 0.30 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 157 / 9693 (1.6%) | 5314 / 96930 (5.5%) | −78.2 | −76.1 | 0.30 |
| FOXA1 SRX1447316 | MCF-7 Breast | 91 / 9693 (0.9%) | 4126 / 96930 (4.3%) | −78.0 | −75.9 | 0.22 |
| ESR1 SRX330070 | MCF-7 Breast | 114 / 9693 (1.2%) | 4552 / 96930 (4.7%) | −77.9 | −75.8 | 0.25 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 207 / 9693 (2.1%) | 6122 / 96930 (6.3%) | −77.7 | −75.6 | 0.34 |
| Epitope tags SRX10549777 | K-562 Blood | 1343 / 9693 (13.9%) | 7651 / 96930 (7.9%) | −77.7 | −75.6 | 1.76 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 215 / 9693 (2.2%) | 6248 / 96930 (6.4%) | −77.7 | −75.6 | 0.34 |
| FOXA1 SRX3931033 | MCF-7 Breast | 147 / 9693 (1.5%) | 5127 / 96930 (5.3%) | −77.7 | −75.6 | 0.29 |
| ESR1 SRX20282953 | MCF-7 Breast | 188 / 9693 (1.9%) | 5808 / 96930 (6.0%) | −77.6 | −75.5 | 0.32 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 221 / 9693 (2.3%) | 6337 / 96930 (6.5%) | −77.5 | −75.4 | 0.35 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 77 / 9693 (0.8%) | 3837 / 96930 (4.0%) | −77.5 | −75.4 | 0.20 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 186 / 9693 (1.9%) | 5773 / 96930 (6.0%) | −77.5 | −75.4 | 0.32 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1052 / 9693 (10.9%) | 5475 / 96930 (5.6%) | −77.3 | −75.3 | 1.92 |
| GATA3 SRX100559 | T-47D Breast | 256 / 9693 (2.6%) | 6877 / 96930 (7.1%) | −77.3 | −75.2 | 0.37 |
| ESR1 SRX10365558 | MCF-7 Breast | 154 / 9693 (1.6%) | 5233 / 96930 (5.4%) | −77.3 | −75.2 | 0.29 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 217 / 9693 (2.2%) | 6268 / 96930 (6.5%) | −77.3 | −75.2 | 0.35 |
| Epitope tags SRX2255894 | 293 Kidney | 749 / 9693 (7.7%) | 3350 / 96930 (3.5%) | −77.2 | −75.2 | 2.24 |
| GATA3 SRX15946407 | MDA-MB-453 Breast | 276 / 9693 (2.8%) | 7169 / 96930 (7.4%) | −77.0 | −74.9 | 0.38 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 226 / 9693 (2.3%) | 6393 / 96930 (6.6%) | −76.8 | −74.8 | 0.35 |
| PGR SRX1012655 | MCF-7 Breast | 146 / 9693 (1.5%) | 5076 / 96930 (5.2%) | −76.7 | −74.6 | 0.29 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 318 / 9693 (3.3%) | 804 / 96930 (0.8%) | −76.6 | −74.5 | 3.96 |
| ESR1 SRX3110725 | MCF-7 Breast | 208 / 9693 (2.1%) | 6099 / 96930 (6.3%) | −76.5 | −74.4 | 0.34 |
| MEAF6 DRX234811 | 293 Kidney | 897 / 9693 (9.3%) | 4387 / 96930 (4.5%) | −76.4 | −74.4 | 2.04 |
| GATA3 SRX11149846 | MDA-MB-453 Breast | 277 / 9693 (2.9%) | 7156 / 96930 (7.4%) | −76.2 | −74.2 | 0.39 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 220 / 9693 (2.3%) | 6267 / 96930 (6.5%) | −75.9 | −73.9 | 0.35 |
| FOXA1 SRX1161207 | T-47D Breast | 91 / 9693 (0.9%) | 4057 / 96930 (4.2%) | −75.8 | −73.7 | 0.22 |
| FOXA1 SRX1961157 | T-47D Breast | 257 / 9693 (2.7%) | 6837 / 96930 (7.1%) | −75.8 | −73.7 | 0.38 |
| ESR1 SRX1012632 | MCF-7 Breast | 113 / 9693 (1.2%) | 4466 / 96930 (4.6%) | −75.8 | −73.7 | 0.25 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 204 / 9693 (2.1%) | 6007 / 96930 (6.2%) | −75.7 | −73.7 | 0.34 |
| ESR1 SRX4367192 | MCF-7 Breast | 478 / 9693 (4.9%) | 10013 / 96930 (10.3%) | −75.5 | −73.5 | 0.48 |
| FOXA1 SRX1787654 | MCF-7 Breast | 84 / 9693 (0.9%) | 3916 / 96930 (4.0%) | −75.5 | −73.5 | 0.21 |
| NCOA3 SRX4663589 | MCF-7 Breast | 59 / 9693 (0.6%) | 3414 / 96930 (3.5%) | −75.4 | −73.4 | 0.17 |
| RELA SRX2207673 | HUVEC Cardiovascular | 814 / 9693 (8.4%) | 14413 / 96930 (14.9%) | −75.3 | −73.3 | 0.56 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 59 / 9693 (0.6%) | 3408 / 96930 (3.5%) | −75.3 | −73.2 | 0.17 |
| FOXA1 SRX3923515 | MCF-7 Breast | 132 / 9693 (1.4%) | 4783 / 96930 (4.9%) | −75.2 | −73.1 | 0.28 |
| ING5 SRX286202 | RKO Digestive tract | 692 / 9693 (7.1%) | 3015 / 96930 (3.1%) | −75.1 | −73.1 | 2.30 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 161 / 9693 (1.7%) | 5278 / 96930 (5.4%) | −75.1 | −73.1 | 0.31 |
| FOXA1 SRX3923519 | MCF-7 Breast | 144 / 9693 (1.5%) | 4990 / 96930 (5.1%) | −75.1 | −73.0 | 0.29 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1129 / 9693 (11.6%) | 6113 / 96930 (6.3%) | −74.8 | −72.8 | 1.85 |
| FOXA1 SRX5203307 | MCF-7 Breast | 67 / 9693 (0.7%) | 3559 / 96930 (3.7%) | −74.8 | −72.8 | 0.19 |
| ESR1 SRX330067 | MCF-7 Breast | 215 / 9693 (2.2%) | 6141 / 96930 (6.3%) | −74.6 | −72.6 | 0.35 |
| ESR1 SRX1012630 | MCF-7 Breast | 86 / 9693 (0.9%) | 3927 / 96930 (4.1%) | −74.6 | −72.5 | 0.22 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 233 / 9693 (2.4%) | 6418 / 96930 (6.6%) | −74.5 | −72.4 | 0.36 |
| ESR1 SRX330068 | MCF-7 Breast | 108 / 9693 (1.1%) | 4334 / 96930 (4.5%) | −74.5 | −72.4 | 0.25 |
| MEAF6 DRX300417 | 293 Kidney | 824 / 9693 (8.5%) | 3926 / 96930 (4.1%) | −74.3 | −72.3 | 2.10 |
| ZFX SRX7805372 | 293 Kidney | 851 / 9693 (8.8%) | 4115 / 96930 (4.2%) | −74.2 | −72.2 | 2.07 |
| ESR1 SRX3123829 | MCF-7 Breast | 135 / 9693 (1.4%) | 4804 / 96930 (5.0%) | −74.2 | −72.1 | 0.28 |
| ESR1 SRX1531796 | MCF-7 Breast | 125 / 9693 (1.3%) | 4627 / 96930 (4.8%) | −74.1 | −72.0 | 0.27 |
| MAU2 SRX11120893 | MCF-7 Breast | 92 / 9693 (0.9%) | 4019 / 96930 (4.1%) | −73.9 | −71.9 | 0.23 |
| FOXA1 SRX1961158 | T-47D Breast | 239 / 9693 (2.5%) | 6490 / 96930 (6.7%) | −73.8 | −71.8 | 0.37 |
| JUN SRX17561461 | LPS141 Adipocyte | 347 / 9693 (3.6%) | 8096 / 96930 (8.4%) | −73.8 | −71.8 | 0.43 |
| Epitope tags SRX7276677 | 293 Kidney | 1453 / 9693 (15.0%) | 8641 / 96930 (8.9%) | −73.7 | −71.7 | 1.68 |
| ESR1 SRX8537722 | MCF-7 Breast | 222 / 9693 (2.3%) | 6219 / 96930 (6.4%) | −73.7 | −71.6 | 0.36 |
| FOXA1 SRX5203294 | MCF-7 Breast | 68 / 9693 (0.7%) | 3544 / 96930 (3.7%) | −73.6 | −71.6 | 0.19 |
| ESR1 SRX2881002 | MCF-7 Breast | 227 / 9693 (2.3%) | 6289 / 96930 (6.5%) | −73.5 | −71.5 | 0.36 |
| FOXA1 SRX5323845 | MCF-7 Breast | 87 / 9693 (0.9%) | 3911 / 96930 (4.0%) | −73.4 | −71.4 | 0.22 |
| FOXA1 SRX15430999 | T-47D Breast | 267 / 9693 (2.8%) | 6898 / 96930 (7.1%) | −73.3 | −71.3 | 0.39 |
| ARID1A SRX5089391 | MCF-7 Breast | 134 / 9693 (1.4%) | 4752 / 96930 (4.9%) | −73.1 | −71.1 | 0.28 |
| NANOG SRX10445309 | Neural crest cells Neural | 128 / 9693 (1.3%) | 4648 / 96930 (4.8%) | −73.0 | −71.0 | 0.28 |
| ESR1 SRX330069 | MCF-7 Breast | 146 / 9693 (1.5%) | 4956 / 96930 (5.1%) | −73.0 | −71.0 | 0.29 |
| RORC SRX5359052 | HCC70 Breast | 708 / 9693 (7.3%) | 3165 / 96930 (3.3%) | −73.0 | −71.0 | 2.24 |
| ESR1 SRX5323873 | MCF-7 Breast | 293 / 9693 (3.0%) | 7272 / 96930 (7.5%) | −72.9 | −70.9 | 0.40 |
| FOXA1 SRX219284 | LNCAP Prostate | 321 / 9693 (3.3%) | 7686 / 96930 (7.9%) | −72.9 | −70.9 | 0.42 |
| GRHL3 SRX2582162 | NHEK Epidermis | 582 / 9693 (6.0%) | 2349 / 96930 (2.4%) | −72.9 | −70.9 | 2.48 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 734 / 9693 (7.6%) | 13267 / 96930 (13.7%) | −72.7 | −70.7 | 0.55 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 221 / 9693 (2.3%) | 6165 / 96930 (6.4%) | −72.6 | −70.6 | 0.36 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 613 / 9693 (6.3%) | 11696 / 96930 (12.1%) | −72.6 | −70.6 | 0.52 |
| ETS1 SRX3033231 | HEYA8 Gonad | 166 / 9693 (1.7%) | 204 / 96930 (0.2%) | −72.5 | −70.5 | 8.14 |
| ESR1 SRX2912055 | MCF-7 Breast | 88 / 9693 (0.9%) | 3895 / 96930 (4.0%) | −72.3 | −70.3 | 0.23 |
| EP300 SRX1012648 | MCF-7 Breast | 114 / 9693 (1.2%) | 4371 / 96930 (4.5%) | −72.2 | −70.2 | 0.26 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 694 / 9693 (7.2%) | 12727 / 96930 (13.1%) | −72.1 | −70.1 | 0.55 |
| ARID5B SRX3230377 | Hep G2 Liver | 590 / 9693 (6.1%) | 11370 / 96930 (11.7%) | −72.1 | −70.1 | 0.52 |
| FOXA1 SRX100477 | Hep G2 Liver | 276 / 9693 (2.8%) | 6985 / 96930 (7.2%) | −72.0 | −70.0 | 0.40 |
| RELA SRX2207672 | HUVEC Cardiovascular | 880 / 9693 (9.1%) | 15072 / 96930 (15.5%) | −72.0 | −70.0 | 0.58 |
| TRPS1 SRX3401273 | MCF-7 Breast | 73 / 9693 (0.8%) | 3594 / 96930 (3.7%) | −71.9 | −70.0 | 0.20 |
| FOXA1 SRX3931056 | MCF-7 Breast | 142 / 9693 (1.5%) | 4851 / 96930 (5.0%) | −71.9 | −69.9 | 0.29 |
| ESR1 SRX20282938 | MCF-7 Breast | 196 / 9693 (2.0%) | 5745 / 96930 (5.9%) | −71.9 | −69.9 | 0.34 |
| FOXA1 SRX1161205 | T-47D Breast | 129 / 9693 (1.3%) | 4622 / 96930 (4.8%) | −71.7 | −69.7 | 0.28 |
| ESR1 SRX8537723 | MCF-7 Breast | 196 / 9693 (2.0%) | 5733 / 96930 (5.9%) | −71.6 | −69.7 | 0.34 |
| KAT7 DRX234808 | 293 Kidney | 419 / 9693 (4.3%) | 1393 / 96930 (1.4%) | −71.6 | −69.6 | 3.01 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 663 / 9693 (6.8%) | 2899 / 96930 (3.0%) | −71.4 | −69.4 | 2.29 |
| VGLL1 SRX18013279 | FULVR Breast | 114 / 9693 (1.2%) | 4343 / 96930 (4.5%) | −71.3 | −69.3 | 0.26 |
| SOX2 SRX512370 | iPS cells Pluripotent stem cell | 39 / 9693 (0.4%) | 2860 / 96930 (3.0%) | −71.2 | −69.2 | 0.14 |
| TP53 SRX396254 | Fibroblasts Others | 461 / 9693 (4.8%) | 1640 / 96930 (1.7%) | −71.2 | −69.2 | 2.81 |
| EP300 SRX1012644 | MCF-7 Breast | 110 / 9693 (1.1%) | 4266 / 96930 (4.4%) | −71.1 | −69.1 | 0.26 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 87 / 9693 (0.9%) | 3839 / 96930 (4.0%) | −71.0 | −69.0 | 0.23 |
| ESR1 SRX20282971 | MCF-7 Breast | 243 / 9693 (2.5%) | 6447 / 96930 (6.7%) | −71.0 | −69.0 | 0.38 |
| EP300 SRX2671813 | Fibroblasts Others | 209 / 9693 (2.2%) | 5916 / 96930 (6.1%) | −70.9 | −68.9 | 0.35 |
| EP300 SRX1012643 | MCF-7 Breast | 85 / 9693 (0.9%) | 3798 / 96930 (3.9%) | −70.9 | −68.9 | 0.22 |
| Epitope tags SRX10549778 | K-562 Blood | 591 / 9693 (6.1%) | 2443 / 96930 (2.5%) | −70.8 | −68.8 | 2.42 |
| ESR1 SRX2513520 | MCF-7 Breast | 155 / 9693 (1.6%) | 5025 / 96930 (5.2%) | −70.5 | −68.6 | 0.31 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 165 / 9693 (1.7%) | 5188 / 96930 (5.4%) | −70.4 | −68.5 | 0.32 |
| FOXA1 SRX497612 | VCaP Prostate | 233 / 9693 (2.4%) | 6265 / 96930 (6.5%) | −70.3 | −68.3 | 0.37 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 258 / 9693 (2.7%) | 6647 / 96930 (6.9%) | −70.3 | −68.3 | 0.39 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 79 / 9693 (0.8%) | 3661 / 96930 (3.8%) | −70.3 | −68.3 | 0.22 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 358 / 9693 (3.7%) | 8108 / 96930 (8.4%) | −70.1 | −68.1 | 0.44 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 201 / 9693 (2.1%) | 5757 / 96930 (5.9%) | −70.0 | −68.0 | 0.35 |
| ESR1 SRX2513521 | MCF-7 Breast | 117 / 9693 (1.2%) | 4354 / 96930 (4.5%) | −70.0 | −68.0 | 0.27 |
| WWTR1 SRX10119378 | MCF 10A Breast | 267 / 9693 (2.8%) | 6769 / 96930 (7.0%) | −69.9 | −67.9 | 0.39 |
| FOXA1 SRX3923511 | MCF-7 Breast | 96 / 9693 (1.0%) | 3968 / 96930 (4.1%) | −69.7 | −67.7 | 0.24 |
| NR3C1 SRX19024866 | MCF-7 Breast | 87 / 9693 (0.9%) | 3799 / 96930 (3.9%) | −69.7 | −67.7 | 0.23 |
| PROX1 SRX3230397 | Hep G2 Liver | 183 / 9693 (1.9%) | 5454 / 96930 (5.6%) | −69.6 | −67.7 | 0.34 |
| ESR1 SRX1469949 | MCF-7 Breast | 144 / 9693 (1.5%) | 4808 / 96930 (5.0%) | −69.6 | −67.6 | 0.30 |
| NUP98 SRX20440536 | Keratinocytes Epidermis | 251 / 9693 (2.6%) | 554 / 96930 (0.6%) | −69.6 | −67.6 | 4.53 |
| FOXA1 SRX5323829 | T-47D Breast | 140 / 9693 (1.4%) | 4737 / 96930 (4.9%) | −69.5 | −67.5 | 0.30 |
| GATA3 SRX11149845 | MDA-MB-453 Breast | 258 / 9693 (2.7%) | 6613 / 96930 (6.8%) | −69.4 | −67.4 | 0.39 |
| ESR1 SRX4451214 | MCF-7 Breast | 215 / 9693 (2.2%) | 5950 / 96930 (6.1%) | −69.3 | −67.4 | 0.36 |
| AR SRX1067067 | LHSAR Prostate | 411 / 9693 (4.2%) | 8820 / 96930 (9.1%) | −69.3 | −67.3 | 0.47 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 102 / 9693 (1.1%) | 4066 / 96930 (4.2%) | −69.3 | −67.3 | 0.25 |
| CHD7 SRX3581504 | iPS cells Pluripotent stem cell | 47 / 9693 (0.5%) | 2982 / 96930 (3.1%) | −69.3 | −67.3 | 0.16 |
| SSRP1 SRX3436566 | HT-1080 Bone | 171 / 9693 (1.8%) | 238 / 96930 (0.2%) | −69.0 | −67.0 | 7.18 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 301 / 9693 (3.1%) | 796 / 96930 (0.8%) | −68.9 | −67.0 | 3.78 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 420 / 9693 (4.3%) | 8932 / 96930 (9.2%) | −68.9 | −67.0 | 0.47 |
| ESR1 SRX1012629 | MCF-7 Breast | 155 / 9693 (1.6%) | 4969 / 96930 (5.1%) | −68.9 | −66.9 | 0.31 |
| ESR1 SRX20282959 | MCF-7 Breast | 106 / 9693 (1.1%) | 4125 / 96930 (4.3%) | −68.9 | −66.9 | 0.26 |
| ESR1 SRX5323877 | MCF-7 Breast | 195 / 9693 (2.0%) | 5622 / 96930 (5.8%) | −68.8 | −66.9 | 0.35 |
| ESR1 SRX5323871 | MCF-7 Breast | 272 / 9693 (2.8%) | 6803 / 96930 (7.0%) | −68.8 | −66.9 | 0.40 |
| FOXA1 SRX6860635 | T-47D Breast | 189 / 9693 (1.9%) | 5520 / 96930 (5.7%) | −68.8 | −66.8 | 0.34 |
| MAU2 SRX11120892 | MCF-7 Breast | 103 / 9693 (1.1%) | 4063 / 96930 (4.2%) | −68.6 | −66.7 | 0.25 |
| CTNNB1 SRX833403 | hESC H1 Pluripotent stem cell | 73 / 9693 (0.8%) | 3494 / 96930 (3.6%) | −68.6 | −66.7 | 0.21 |
| FOXA1 SRX6878603 | LNCAP Prostate | 273 / 9693 (2.8%) | 6808 / 96930 (7.0%) | −68.6 | −66.7 | 0.40 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 147 / 9693 (1.5%) | 4825 / 96930 (5.0%) | −68.5 | −66.6 | 0.30 |
| FOXA1 SRX5323846 | MCF-7 Breast | 97 / 9693 (1.0%) | 3948 / 96930 (4.1%) | −68.4 | −66.5 | 0.25 |
| FOXA1 SRX3931032 | MCF-7 Breast | 147 / 9693 (1.5%) | 4820 / 96930 (5.0%) | −68.4 | −66.5 | 0.30 |
| AR SRX15946405 | MDA-MB-453 Breast | 159 / 9693 (1.6%) | 5020 / 96930 (5.2%) | −68.4 | −66.4 | 0.32 |
| ZEB1 SRX13298925 | MCF-7 Breast | 157 / 9693 (1.6%) | 4981 / 96930 (5.1%) | −68.3 | −66.4 | 0.32 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 478 / 9693 (4.9%) | 9692 / 96930 (10.0%) | −68.2 | −66.2 | 0.49 |
| ESR1 SRX5534831 | MCF-7 Breast | 194 / 9693 (2.0%) | 5570 / 96930 (5.7%) | −67.9 | −66.0 | 0.35 |
| TCF12 SRX190356 | SK-N-SH Neural | 647 / 9693 (6.7%) | 11919 / 96930 (12.3%) | −67.9 | −66.0 | 0.54 |
| TEAD4 SRX190301 | hESC H1 Pluripotent stem cell | 175 / 9693 (1.8%) | 5263 / 96930 (5.4%) | −67.8 | −65.9 | 0.33 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 881 / 9693 (9.1%) | 4489 / 96930 (4.6%) | −67.7 | −65.8 | 1.96 |
| ARID1A SRX5089385 | MCF-7 Breast | 189 / 9693 (1.9%) | 5481 / 96930 (5.7%) | −67.7 | −65.8 | 0.34 |
| JUNB SRX10119386 | MCF 10A Breast | 233 / 9693 (2.4%) | 6166 / 96930 (6.4%) | −67.6 | −65.7 | 0.38 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 74 / 9693 (0.8%) | 3484 / 96930 (3.6%) | −67.6 | −65.7 | 0.21 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 219 / 9693 (2.3%) | 5949 / 96930 (6.1%) | −67.5 | −65.6 | 0.37 |
| ESR1 SRX2513517 | MCF-7 Breast | 173 / 9693 (1.8%) | 5216 / 96930 (5.4%) | −67.5 | −65.5 | 0.33 |
| FOXA1 SRX9604647 | LNCAP Prostate | 371 / 9693 (3.8%) | 8185 / 96930 (8.4%) | −67.4 | −65.5 | 0.45 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 192 / 9693 (2.0%) | 5521 / 96930 (5.7%) | −67.4 | −65.5 | 0.35 |
| AR SRX9109110 | MDA-MB-453 Breast | 463 / 9693 (4.8%) | 9444 / 96930 (9.7%) | −67.1 | −65.2 | 0.49 |
| FOXA1 SRX2642368 | VCaP Prostate | 304 / 9693 (3.1%) | 7204 / 96930 (7.4%) | −67.0 | −65.1 | 0.42 |
| AR SRX11149848 | MDA-MB-453 Breast | 162 / 9693 (1.7%) | 5021 / 96930 (5.2%) | −67.0 | −65.0 | 0.32 |
| FOXA1 SRX3931031 | MCF-7 Breast | 121 / 9693 (1.2%) | 4328 / 96930 (4.5%) | −67.0 | −65.0 | 0.28 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 346 / 9693 (3.6%) | 1050 / 96930 (1.1%) | −66.9 | −65.0 | 3.30 |
| ESR1 SRX5323872 | MCF-7 Breast | 253 / 9693 (2.6%) | 6446 / 96930 (6.7%) | −66.9 | −65.0 | 0.39 |
| MethylCap SRX026646 | Acute myeloid leukemia Blood | 352 / 9693 (3.6%) | 1083 / 96930 (1.1%) | −66.9 | −65.0 | 3.25 |
| CDK9 SRX7366779 | MCF-7 Breast | 119 / 9693 (1.2%) | 91 / 96930 (0.1%) | −66.8 | −64.8 | 13.08 |
| Epitope tags DRX443510 | 293 Kidney | 750 / 9693 (7.7%) | 3588 / 96930 (3.7%) | −66.7 | −64.8 | 2.09 |
| NR3C1 SRX19024870 | MCF-7 Breast | 85 / 9693 (0.9%) | 3671 / 96930 (3.8%) | −66.7 | −64.8 | 0.23 |
| NANOG SRX2881137 | hESC H9 Pluripotent stem cell | 71 / 9693 (0.7%) | 3399 / 96930 (3.5%) | −66.7 | −64.8 | 0.21 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 167 / 9693 (1.7%) | 5089 / 96930 (5.3%) | −66.6 | −64.7 | 0.33 |
| ZEB1 SRX13298924 | MCF-7 Breast | 123 / 9693 (1.3%) | 4351 / 96930 (4.5%) | −66.6 | −64.7 | 0.28 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 825 / 9693 (8.5%) | 4118 / 96930 (4.2%) | −66.5 | −64.6 | 2.00 |
| KDM6A SRX15826236 | MCF-7 Breast | 81 / 9693 (0.8%) | 3587 / 96930 (3.7%) | −66.5 | −64.6 | 0.23 |
| SMARCA4 SRX5212362 | Mel270 Others | 429 / 9693 (4.4%) | 8950 / 96930 (9.2%) | −66.4 | −64.5 | 0.48 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 574 / 9693 (5.9%) | 10893 / 96930 (11.2%) | −66.4 | −64.5 | 0.53 |
| ARID1A SRX5089388 | MCF-7 Breast | 134 / 9693 (1.4%) | 4531 / 96930 (4.7%) | −66.3 | −64.4 | 0.30 |
| NKX2-1 SRX2164786 | A549 Lung | 419 / 9693 (4.3%) | 8805 / 96930 (9.1%) | −66.2 | −64.3 | 0.48 |
| ESR1 SRX1161184 | ZR-75-1 Breast | 40 / 9693 (0.4%) | 2744 / 96930 (2.8%) | −66.2 | −64.3 | 0.15 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 244 / 9693 (2.5%) | 6281 / 96930 (6.5%) | −66.2 | −64.3 | 0.39 |
| SOX13 SRX2636248 | Hep G2 Liver | 348 / 9693 (3.6%) | 7804 / 96930 (8.1%) | −66.1 | −64.2 | 0.45 |
| RBFOX2 SRX4708082 | K-562 Blood | 1245 / 9693 (12.8%) | 7275 / 96930 (7.5%) | −66.0 | −64.1 | 1.71 |
| ESR1 SRX20282966 | MCF-7 Breast | 89 / 9693 (0.9%) | 3721 / 96930 (3.8%) | −66.0 | −64.1 | 0.24 |
| ESR1 SRX5323878 | MCF-7 Breast | 256 / 9693 (2.6%) | 6456 / 96930 (6.7%) | −65.9 | −64.1 | 0.40 |
| TFAP2C SRX018833 | MCF-7 Breast | 232 / 9693 (2.4%) | 6091 / 96930 (6.3%) | −65.9 | −64.0 | 0.38 |
| FOXA2 SRX11650945 | hESC derived pancreatic cells Pluripotent stem cell | 159 / 9693 (1.6%) | 4932 / 96930 (5.1%) | −65.8 | −63.9 | 0.32 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 100 / 9693 (1.0%) | 3917 / 96930 (4.0%) | −65.8 | −63.9 | 0.26 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 205 / 9693 (2.1%) | 5663 / 96930 (5.8%) | −65.7 | −63.8 | 0.36 |
| IRF3 SRX11453864 | Hep G2 Liver | 91 / 9693 (0.9%) | 34 / 96930 (0.0%) | −65.6 | −63.8 | 26.76 |
| NR3C1 SRX1161167 | MCF-7 Breast | 68 / 9693 (0.7%) | 3309 / 96930 (3.4%) | −65.6 | −63.7 | 0.21 |
| EP300 SRX150579 | HeLa Uterus | 173 / 9693 (1.8%) | 5153 / 96930 (5.3%) | −65.6 | −63.7 | 0.34 |
| TFAP2C SRX128099 | MCF-7 Breast | 233 / 9693 (2.4%) | 6091 / 96930 (6.3%) | −65.6 | −63.7 | 0.38 |
| FOXM1 SRX185907 | MCF-7 Breast | 48 / 9693 (0.5%) | 2892 / 96930 (3.0%) | −65.3 | −63.4 | 0.17 |
| NCOA1 SRX036638 | U2OS Bone | 96 / 9693 (1.0%) | 44 / 96930 (0.0%) | −65.2 | −63.4 | 21.82 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 524 / 9693 (5.4%) | 10181 / 96930 (10.5%) | −65.2 | −63.3 | 0.51 |
| VGLL1 SRX24602134 | BeWo Placenta | 193 / 9693 (2.0%) | 5455 / 96930 (5.6%) | −65.2 | −63.3 | 0.35 |
| FOXA1 SRX6878604 | LNCAP Prostate | 207 / 9693 (2.1%) | 5674 / 96930 (5.9%) | −65.2 | −63.3 | 0.36 |
| FOXA1 SRX219285 | LNCAP Prostate | 242 / 9693 (2.5%) | 6214 / 96930 (6.4%) | −65.1 | −63.3 | 0.39 |
| FOXA1 SRX2017929 | LNCAP Prostate | 334 / 9693 (3.4%) | 7565 / 96930 (7.8%) | −65.1 | −63.2 | 0.44 |
| PGR SRX3990986 | T-47D Breast | 224 / 9693 (2.3%) | 5937 / 96930 (6.1%) | −65.1 | −63.2 | 0.38 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 174 / 9693 (1.8%) | 5151 / 96930 (5.3%) | −65.0 | −63.1 | 0.34 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 585 / 9693 (6.0%) | 10970 / 96930 (11.3%) | −64.9 | −63.0 | 0.53 |
| TEAD1 SRX1011298 | HuCCT1 Liver | 112 / 9693 (1.2%) | 4099 / 96930 (4.2%) | −64.8 | −62.9 | 0.27 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 843 / 9693 (8.7%) | 14248 / 96930 (14.7%) | −64.8 | −62.9 | 0.59 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 259 / 9693 (2.7%) | 6455 / 96930 (6.7%) | −64.7 | −62.9 | 0.40 |
| ARID1A SRX5089382 | MCF-7 Breast | 187 / 9693 (1.9%) | 5342 / 96930 (5.5%) | −64.7 | −62.8 | 0.35 |
| GATAD2A SRX2636506 | Hep G2 Liver | 329 / 9693 (3.4%) | 7472 / 96930 (7.7%) | −64.6 | −62.8 | 0.44 |
| FOXA1 SRX1885182 | LNCAP Prostate | 224 / 9693 (2.3%) | 5914 / 96930 (6.1%) | −64.5 | −62.6 | 0.38 |
| AR SRX10365514 | MCF-7 Breast | 60 / 9693 (0.6%) | 3114 / 96930 (3.2%) | −64.4 | −62.6 | 0.19 |
| ESR1 SRX1012633 | MCF-7 Breast | 137 / 9693 (1.4%) | 4517 / 96930 (4.7%) | −64.4 | −62.5 | 0.30 |
| AR SRX9469987 | LAPC-4 Prostate | 122 / 9693 (1.3%) | 4259 / 96930 (4.4%) | −64.4 | −62.5 | 0.29 |
| FOXA1 SRX1885181 | LNCAP Prostate | 236 / 9693 (2.4%) | 6090 / 96930 (6.3%) | −64.3 | −62.5 | 0.39 |
| CEBPA SRX2630241 | Hep G2 Liver | 318 / 9693 (3.3%) | 7296 / 96930 (7.5%) | −64.2 | −62.3 | 0.44 |
| Epitope tags SRX5877912 | U2OS Bone | 1317 / 9693 (13.6%) | 19903 / 96930 (20.5%) | −64.2 | −62.3 | 0.66 |
| ESR1 SRX1469951 | MCF-7 Breast | 138 / 9693 (1.4%) | 4522 / 96930 (4.7%) | −64.1 | −62.2 | 0.31 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 562 / 9693 (5.8%) | 2384 / 96930 (2.5%) | −64.1 | −62.2 | 2.36 |
| ESR1 SRX1012625 | MCF-7 Breast | 139 / 9693 (1.4%) | 4539 / 96930 (4.7%) | −64.1 | −62.2 | 0.31 |
| AHR SRX20282969 | MCF-7 Breast | 123 / 9693 (1.3%) | 4267 / 96930 (4.4%) | −64.0 | −62.2 | 0.29 |
| VGLL1 SRX18013278 | FULVR Breast | 124 / 9693 (1.3%) | 4283 / 96930 (4.4%) | −64.0 | −62.1 | 0.29 |
| FOXA1 SRX8537736 | MCF-7 Breast | 93 / 9693 (1.0%) | 3732 / 96930 (3.9%) | −63.9 | −62.0 | 0.25 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 271 / 9693 (2.8%) | 6597 / 96930 (6.8%) | −63.8 | −62.0 | 0.41 |
| TEAD1 SRX716558 | SF268 Neural | 134 / 9693 (1.4%) | 4446 / 96930 (4.6%) | −63.8 | −61.9 | 0.30 |
| FOS SRX4192879 | MCF 10A Breast | 309 / 9693 (3.2%) | 7142 / 96930 (7.4%) | −63.6 | −61.8 | 0.43 |
| GATA2 SRX16314544 | Trophoblast stem cells Placenta | 171 / 9693 (1.8%) | 5049 / 96930 (5.2%) | −63.6 | −61.7 | 0.34 |
| AR SRX9109113 | MDA-MB-453 Breast | 483 / 9693 (5.0%) | 9552 / 96930 (9.9%) | −63.4 | −61.5 | 0.51 |
| FOXA1 SRX3923513 | MCF-7 Breast | 84 / 9693 (0.9%) | 3549 / 96930 (3.7%) | −63.4 | −61.5 | 0.24 |
| FOXA1 SRX3923508 | MCF-7 Breast | 86 / 9693 (0.9%) | 3587 / 96930 (3.7%) | −63.4 | −61.5 | 0.24 |
| ERG SRX063921 | K-562 Blood | 774 / 9693 (8.0%) | 3838 / 96930 (4.0%) | −63.4 | −61.5 | 2.02 |
| FOXA1 SRX497613 | VCaP Prostate | 190 / 9693 (2.0%) | 5342 / 96930 (5.5%) | −63.3 | −61.5 | 0.36 |
| ESR1 SRX3110720 | MCF-7 Breast | 111 / 9693 (1.1%) | 4035 / 96930 (4.2%) | −63.3 | −61.4 | 0.28 |
| NR3C1 SRX19024880 | MCF-7 Breast | 70 / 9693 (0.7%) | 3281 / 96930 (3.4%) | −63.3 | −61.4 | 0.21 |
| MECOM SRX23677890 | HNT-34 Blood | 943 / 9693 (9.7%) | 5066 / 96930 (5.2%) | −63.3 | −61.4 | 1.86 |
| DLX5 SRX17306262 | Trophoblast stem cells Placenta | 313 / 9693 (3.2%) | 7185 / 96930 (7.4%) | −63.2 | −61.4 | 0.44 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 257 / 9693 (2.7%) | 6367 / 96930 (6.6%) | −63.2 | −61.4 | 0.40 |
| FOXA1 SRX6860646 | T-47D Breast | 154 / 9693 (1.6%) | 4758 / 96930 (4.9%) | −63.2 | −61.3 | 0.32 |
| FOXA1 SRX3931073 | MCF-7 Breast | 161 / 9693 (1.7%) | 4871 / 96930 (5.0%) | −63.0 | −61.2 | 0.33 |
| KMT2C SRX1787675 | MCF-7 Breast | 232 / 9693 (2.4%) | 5979 / 96930 (6.2%) | −63.0 | −61.2 | 0.39 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 601 / 9693 (6.2%) | 11089 / 96930 (11.4%) | −63.0 | −61.1 | 0.54 |
| CBX3 SRX6712570 | MCF-7 Breast | 209 / 9693 (2.2%) | 5625 / 96930 (5.8%) | −63.0 | −61.1 | 0.37 |
| ESR1 SRX3110723 | MCF-7 Breast | 147 / 9693 (1.5%) | 4636 / 96930 (4.8%) | −62.9 | −61.1 | 0.32 |
| NANOG SRX2881138 | hESC H9 Pluripotent stem cell | 42 / 9693 (0.4%) | 2693 / 96930 (2.8%) | −62.8 | −61.0 | 0.16 |
| GATA3 SRX3292068 | hESC derived trophoblast cells Pluripotent stem cell | 58 / 9693 (0.6%) | 3027 / 96930 (3.1%) | −62.8 | −61.0 | 0.19 |
| FOXL2 SRX6957431 | KGN Gonad | 574 / 9693 (5.9%) | 10725 / 96930 (11.1%) | −62.8 | −61.0 | 0.54 |
| FOXA1 SRX15391842 | T-47D Breast | 152 / 9693 (1.6%) | 4710 / 96930 (4.9%) | −62.7 | −60.8 | 0.32 |
| FOXA2 SRX11650947 | hESC derived pancreatic cells Pluripotent stem cell | 180 / 9693 (1.9%) | 5158 / 96930 (5.3%) | −62.6 | −60.8 | 0.35 |
| FOXA2 SRX11650943 | hESC derived pancreatic cells Pluripotent stem cell | 168 / 9693 (1.7%) | 4967 / 96930 (5.1%) | −62.6 | −60.7 | 0.34 |
| FOXA1 SRX5323844 | MCF-7 Breast | 78 / 9693 (0.8%) | 3412 / 96930 (3.5%) | −62.5 | −60.7 | 0.23 |
| SOX2 SRX5771666 | N2102Ep Gonad | 58 / 9693 (0.6%) | 3018 / 96930 (3.1%) | −62.5 | −60.7 | 0.19 |
| FOXA2 SRX11650946 | hESC derived pancreatic cells Pluripotent stem cell | 137 / 9693 (1.4%) | 4454 / 96930 (4.6%) | −62.5 | −60.6 | 0.31 |
| FOXA1 SRX5203311 | MCF-7 Breast | 47 / 9693 (0.5%) | 2786 / 96930 (2.9%) | −62.3 | −60.5 | 0.17 |
| FOXA1 SRX1885184 | LNCAP Prostate | 245 / 9693 (2.5%) | 6149 / 96930 (6.3%) | −62.3 | −60.5 | 0.40 |
| FOXA1 SRX2642367 | VCaP Prostate | 233 / 9693 (2.4%) | 5969 / 96930 (6.2%) | −62.3 | −60.4 | 0.39 |
| CEBPB SRX190345 | MCF-7 Breast | 210 / 9693 (2.2%) | 5612 / 96930 (5.8%) | −62.2 | −60.4 | 0.37 |
| FOXA1 SRX667985 | VCaP Prostate | 208 / 9693 (2.1%) | 5585 / 96930 (5.8%) | −62.2 | −60.4 | 0.37 |
| EP300 SRX176883 | MCF-7 Breast | 131 / 9693 (1.4%) | 4339 / 96930 (4.5%) | −62.1 | −60.3 | 0.30 |
| KMT2C SRX1787676 | MCF-7 Breast | 58 / 9693 (0.6%) | 3003 / 96930 (3.1%) | −62.1 | −60.2 | 0.19 |
| ESR1 SRX176856 | MCF-7 Breast | 96 / 9693 (1.0%) | 3720 / 96930 (3.8%) | −61.8 | −60.0 | 0.26 |
| ESR1 SRX5323874 | MCF-7 Breast | 163 / 9693 (1.7%) | 4860 / 96930 (5.0%) | −61.8 | −60.0 | 0.34 |
| NANOG SRX702040 | hESC HUES64 Pluripotent stem cell | 58 / 9693 (0.6%) | 2997 / 96930 (3.1%) | −61.7 | −59.9 | 0.19 |
| FOXA2 SRX11650941 | hESC derived pancreatic cells Pluripotent stem cell | 136 / 9693 (1.4%) | 4408 / 96930 (4.5%) | −61.7 | −59.9 | 0.31 |
| FOXA1 SRX1161202 | T-47D Breast | 109 / 9693 (1.1%) | 3941 / 96930 (4.1%) | −61.6 | −59.7 | 0.28 |
Showing first 500 of 14309 rows.